Expert recommendations on the management of hypertension in patients with ovarian and cervical cancer receiving bevacizumab in the UK

Overview of attention for article published in British Journal of Cancer, June 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

news: 1 news outlet
policy: 1 policy source

twitter: 17 X users
guideline: 1 clinical guideline source

Readers on

mendeley: 83 Mendeley

So far, Altmetric has seen 20 X posts from 17 X users, with an upper bound of 34,119 followers.

@PaulHannaMD @kdjhaveri @jordy_bc @HerrmannMd @onconephsociety https://t.co/VQJj5N8HPk

RT @portorenal: Among CCB, Amlodipine is the chosen one as @SwethaKanduriMD 👏 pretty well explained! Here some referrences and what to do w…

Among CCB, Amlodipine is the chosen one as @SwethaKanduriMD 👏 pretty well explained! Here some referrences and what to do when facing proteinuria. ➡️https://t.co/XqatNrANFq ➡️ https://t.co/EKgkWIIGD2

#ThrowbackThursday Consensus statement with recommendations on the management of #hypertension in patients with ovarian and cervical cancer receiving bevacizumab by Chris Plummer and colleagues #OvarianCancerAwarenessMonth #cervicalcancer https://t.…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 16 additional X posts.